Notably, the transcriptional regulation of Fpn by Hif2α has also been well described,[20, 22, 29] these important findings have created new therapeutic opportunities for the treatment of hemochromatosis and anemia. The gene discussed is SLC40A1; the disease is anemia (phenotype).